NUCLISENS? MAGNETIC SILICA 280133

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2018-01-31 for NUCLISENS? MAGNETIC SILICA 280133 manufactured by Biom?rieux Sa.

Event Text Entries

[99001942] An investigation was performed. Many experiments were performed on (b)(6) applications which did not reproduce the issue. Several silica batches were tested: z018ek1ms, z018cd1ms and z018fl1ms for (b)(6) application and z018ek1ms, z017kg1ms and z018fl1ms for (b)(6) application. An additional (b)(6) application (b)(6) was also tested in order to mimic the ic structure. There was no significant difference observed on ic ct between silica batches. The impact of the sample volume was tested: 200 ul of plasma (as claimed for most of the validated biomerieux's downstream applications) versus 1 ml (as used in the customer's test) were extracted. No significant difference was observed between silica batches on positive and/ or internal controls, whatever the sample input volume tested. The silica batch z018ek1ms conformed with (b)(6) applications. Moreover, real time stability testing was performed on one representative batch of silica from each lot (made from the same raw materials). The nucl. Magn. Silica 384t batch z018ek1ms was made from the same raw material as the silica batch z018eh1ms. All the tests performed on this reference batch, including rna applications (flu and mengo targets), conformed to specifications. The nuclisens? Magnetic silica 384t (lot z018ek1ms) performed within specifications.
Patient Sequence No: 1, Text Type: N, H10


[99001943] A customer from the united states reported a performance problem with internal control samples in association with nuclisens? Magnetic silica (lot z018ek1ms), when testing (b)(6) on plasma. The customer stated that as they started using lot z018ek1ms on (b)(6) 2017, almost half of the internal control samples started to have higher ct values (34 and 35) than normal. The customer reported that the generic protocol was used and the internal control was a (b)(6) in the (b)(6) family. The customer started they had to extract less sample (200ul instead of the normal 900ul) in order to have the internal control work appropriately. As a result, the sensitivity of the assay to detect (b)(6) decreased, so there was a possibility they missed detecting (b)(6), as patients infected with (b)(6) have very low amounts of (b)(6) present in their plasma. The customer stated that no wrong results were reported to the physician, as they repeated the sample until the internal control was within range. The patient reports included the volume of sample tested and the limits of detection with different sample volumes. The customer reported there were delays for reporting results as they had to repeat many runs (using lower sample volumes) to get the internal control values within range. There is no indication or report from the hospital or treating physician to biom? Rieux that the issue led to any adverse event related to any patient's state of health.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3002769706-2018-00010
MDR Report Key7231392
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2018-01-31
Date of Report2018-01-31
Date of Event2017-09-06
Date Mfgr Received2017-11-07
Device Manufacturer Date2017-06-23
Date Added to Maude2018-01-31
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMRS. ELLEN WELTMER
Manufacturer Street595 ANGLUM ROAD
Manufacturer CityST. LOUIS MO 63042
Manufacturer CountryUS
Manufacturer Postal63042
Manufacturer Phone3147317301
Manufacturer G1BIOM
Manufacturer Street5, RUE DES BERGES
Manufacturer CityGRENOBLE CEDEX 01, FR 38024
Manufacturer CountryFR
Manufacturer Postal Code38024
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNUCLISENS? MAGNETIC SILICA
Generic NameNUCLISENS? MAGNETIC SILICA
Product CodeLDT
Date Received2018-01-31
Catalog Number280133
Lot NumberZ018EK1MS
ID Number03573026139339
Device Expiration Date2018-05-28
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBIOM?RIEUX SA
Manufacturer Address5, RUE DES BERGES GRENOBLE CEDEX 01, FR 38024 FR 38024


Patients

Patient NumberTreatmentOutcomeDate
10 2018-01-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.